1-3 of 3
Sean Scott
Close
Sort by
Journal Articles

EDIT-301: An Experimental Autologous Cell Therapy Comprising Cas12a-RNP Modified mPB-CD34+ Cells for the Potential Treatment of SCD

Edouard De Dreuzy, PhD, Jack Heath, John A Zuris, PhD, Patricia Sousa, Ramya Viswanathan, Sean Scott, Jen Da Silva, Terence Ta, PhD, Stacy Capehart, PhD, Tongyao Wang, Cecilia Fernandez, PhD, Vic E Myer, PhD, Charles F Albright, PhD, Christopher J Wilson, PhD, Sandra Teixeira, PhD, Kai-Hsin Chang, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4636.
https://doi.org/10.1182/blood-2019-130256
Published: 2019
Journal Articles

Molecular Subtype Classification of Diffuse Large B-Cell Lymphoma By Immunohistochemical Algorithms and Automatic Supervised Classifiers

Yocanxóchitl Perfecto-Avalos, PhD, Luis Villela, MD, Alejandro Garcia-Gonzalez, PhD, Ana G. Hernández-Reynoso, MS, Gildardo Sánchez-Ante, PhD, Rita Q. Fuentes-Aguilar, PhD, Sean Scott, PhD, Carlos Ortiz-Hidalgo, MD, Jose Borbolla Escoboza, MD
Journal: Blood
Blood (2016) 128 (22): 4229.
https://doi.org/10.1182/blood.V128.22.4229.4229
Published: 2016
Journal Articles

GPX3 Level in Serum of Diffuse Large B Cell Lymphoma Patients Is a Predictive Biomarker for Refractoriness Before Treatment

Luis Villela, MD, Oscar Fajardo, MSc, Darinka Leon, MD, Jose A Hernandez-Hernandez, PhD, Sean Scott, PhD, Sergio Encarnacion, PhD
Journal: Blood
Blood (2012) 120 (21): 5102.
https://doi.org/10.1182/blood.V120.21.5102.5102
Published: 2012